Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155608 · ClinicalTrials.gov registry record · NA
Trigeminal Nerve Stimulation for ADHD
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02155608 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 62 participants.
The verdict
NCT02155608, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to develop external Trigeminal Nerve Stimulation (eTNS) as a potential nonmedication treatment for attention-deficit/hyperactivity disorder (ADHD). Study hypothesis address potential differences over 4 weeks of active vs. sham eTNS treatment on ADHD symptoms, measures of executive function, electroencephalography (EEG) profiles, other dimensional measures of height, weight, mood, anxiety, and sleep, and side effect profiles.
Interventions
- DEVICE Active eTNS
- DEVICE Sham eTNS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2018-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155608
The ClinicalTrials.gov registry entry for NCT02155608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active eTNS is the first listed.
NCT02155608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02155608 about?
NCT02155608 is a clinical study titled "Trigeminal Nerve Stimulation for ADHD". The purpose of this study is to develop external Trigeminal Nerve Stimulation (eTNS) as a potential nonmedication treatment for attention-deficit/hyperactivity disorder (ADHD). Study hypothesis address potential differences over 4 weeks of active vs. sham eTNS treatment on ADHD symptoms, measures o...
What is the current status of trial NCT02155608?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-04-01. Estimated completion is 2018-05-30.
What interventions are being tested in trial NCT02155608?
The interventions under investigation include: Active eTNS (DEVICE), Sham eTNS (DEVICE).
Who is sponsoring clinical trial NCT02155608?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.